Literature DB >> 9693094

Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis.

N S Brown1, R Bicknell.   

Abstract

Angiogenesis is the term used to describe the formation of new blood vessels from the existing vasculature. In order to attract new vessels, a tissue must release an endothelial-cell chemoattractant. 2-Deoxy-D-ribose is produced in vivo by the catalytic action of thymidine phosphorylase (TP) on thymidine and has recently been identified as an endothelial-cell chemoattractant and angiogenesis-inducing factor. TP, previously known only for its role in nucleotide salvage, is now known to be angiogenic. TP expression is elevated in many solid tumours and in chronically inflamed tissues, both known areas of active angiogenesis. There is evidence that TP is also involved in physiological angiogenesis such as endometrial angiogenesis during the menstrual cycle. The majority of known endothelial-cell chemoattractants are polypeptides that bind to endothelial-cell-surface receptors. In contrast, 2-deoxy-D-ribose appears to lack a cell-surface receptor. Glucose is another sugar that acts as an endothelial-cell chemoattractant. The migratory activity of glucose is blocked by ouabain. It is possible that 2-deoxy-D-ribose and glucose stimulate endothelial-cell migration via a similar mechanistic pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693094      PMCID: PMC1219653          DOI: 10.1042/bj3340001

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  88 in total

1.  Purification and properties of thymidine phosphorylase from Salmonella typhimurium.

Authors:  J G Blank; P A Hoffee
Journal:  Arch Biochem Biophys       Date:  1975-05       Impact factor: 4.013

2.  The enzymatic synthesis of nucleosides. I. Thymidine phosphorylase in mammalian tissue.

Authors:  M FRIEDKIN; D ROBERTS
Journal:  J Biol Chem       Date:  1954-03       Impact factor: 5.157

3.  Studies on the energy metabolism of pig red cells. I. The limiting role of membrane permeability in glycolysis.

Authors:  H D Kim; T J McManus
Journal:  Biochim Biophys Acta       Date:  1971-01-26

4.  Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.

Authors:  A Kono; Y Hara; S Sugata; Y Karube; Y Matsushima; H Ishitsuka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1983-01       Impact factor: 1.645

5.  Catabolism of thymidine in human blood platelets: purification and properties of thymidine phosphorylase.

Authors:  C Desgranges; G Razaka; M Rabaud; H Bricaud
Journal:  Biochim Biophys Acta       Date:  1981-07-27

6.  High concentrations of immunoreactive gliostatin/platelet-derived endothelial cell growth factor in synovial fluid and serum of rheumatoid arthritis.

Authors:  K Asai; T Hirano; K Matsukawa; J Kusada; M Takeuchi; T Otsuka; N Matsui; T Kato
Journal:  Clin Chim Acta       Date:  1993-09-17       Impact factor: 3.786

7.  Cytotoxic and biochemical effects of thymidine and 3-deazauridine on human tumor cells.

Authors:  A Lockshin; J T Mendoza; B C Giovanella; J S Stehlin
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

8.  Purification and properties of an endothelial cell growth factor from human platelets.

Authors:  K Miyazono; T Okabe; A Urabe; F Takaku; C H Heldin
Journal:  J Biol Chem       Date:  1987-03-25       Impact factor: 5.157

9.  Purification of thymidine phosphorylase from human amniochorion.

Authors:  J Kubilus; L D Lee; H P Baden
Journal:  Biochim Biophys Acta       Date:  1978-11-10

10.  Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.

Authors:  M I Koukourakis; A Giatromanolaki; K J O'Byrne; M Comley; R M Whitehouse; D C Talbot; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  50 in total

1.  Analysis of the transcriptional program induced by Raf in epithelial cells.

Authors:  A Schulze; K Lehmann; H B Jefferies; M McMahon; J Downward
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

2.  Thymidine phosphorylase expression in endometrial carcinomas.

Authors:  E Sivridis; A Giatromanolaki; M I Koukourakis; R Bicknell; A L Harris; K C Gatter
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

3.  Probing the active site of the deoxynucleotide N-hydrolase Rcl encoded by the rat gene c6orf108.

Authors:  Christelle Dupouy; Chi Zhang; André Padilla; Sylvie Pochet; Pierre Alexandre Kaminski
Journal:  J Biol Chem       Date:  2010-10-20       Impact factor: 5.157

4.  Differential expression of uridine phosphorylase in tumors contributes to an improved fluoropyrimidine therapeutic activity.

Authors:  Deliang Cao; Amy Ziemba; James McCabe; Ruilan Yan; Laxiang Wan; Bradford Kim; Michael Gach; Stuart Flynn; Giuseppe Pizzorno
Journal:  Mol Cancer Ther       Date:  2011-09-27       Impact factor: 6.261

5.  Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration.

Authors:  Jian Zhou; Yong-Sheng Xiao; Zhao-You Tang; Jia Fan; Zhi-Quan Wu; Yan Zhao; Qiong Xue; Zao-Zhuo Shen; Yin-Kun Liu; Sheng-Long Ye
Journal:  J Cancer Res Clin Oncol       Date:  2005-04-30       Impact factor: 4.553

6.  Transition state analysis of the arsenolytic depyrimidination of thymidine by human thymidine phosphorylase.

Authors:  Phillip A Schwartz; Mathew J Vetticatt; Vern L Schramm
Journal:  Biochemistry       Date:  2011-02-03       Impact factor: 3.162

Review 7.  Angiogenic growth factors in myocardial infarction: a critical appraisal.

Authors:  Hemalatha Thiagarajan; UmaMaheswari Thiyagamoorthy; Iswariya Shanmugham; Gunadharini Dharmalingam Nandagopal; Anbukkarasi Kaliyaperumal
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

8.  Dihydropyrimidine dehydrogenase in normal and malignant endometrium: relationship with cell proliferation and thymidine phosphorylase.

Authors:  Ritsuto Fujiwaki; Kohji Iida; Kentaro Nakayama; Haruhiko Kanasaki; Tomoya Ozaki; Kohkichi Hata; Eiichi Sakai; Kohji Miyazaki
Journal:  Virchows Arch       Date:  2003-08-09       Impact factor: 4.064

9.  Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine.

Authors:  Kazumi Uchida; Peter V Danenberg; Kathleen D Danenberg; Jean L Grem
Journal:  BMC Cancer       Date:  2008-12-23       Impact factor: 4.430

Review 10.  Intra-tumoural microvessel density in human solid tumours.

Authors:  J Hasan; R Byers; G C Jayson
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.